Washington State Health Care Authority

The committee discussed Washington hospital costs, price, and profit analysis, including a review of second-level analysis methodology and adjustments for benchmarking. Updates were provided on primary care claims-based measurements and the distinction between benchmark analysis and cost growth driver analysis. The committee also covered data sources and specifications for the 2023 benchmark data call, the application of risk-adjustment metrics, and an overview of the cost driver analysis using All-Payer Claims Database data.

The board meeting agenda includes a legislative session update, a review of OnPoint's cost driver analysis, an analytic support initiative presentation on cost growth trends, and a follow-up discussion on the National Academy for State Health Policy's model regarding transaction oversight, corporate practice of medicine, and transparency.

The committee meeting focused on business oversight regarding healthcare market transactions, including mergers, acquisitions, and private equity investments. Representatives from various state agencies presented on their data collection and oversight roles, highlighting challenges such as fragmented data sources, confidentiality limitations, and the need for more comprehensive tracking of ownership and affiliation data to understand consumer impacts. The committee discussed policy options, potential data gaps, and future steps to enhance healthcare affordability analysis and regulatory transparency.

The committee discussed primary care investment strategies, including a presentation on approaches used in Rhode Island and the examination of code-level primary care definitions for data analysis and reporting. Members reviewed and voted on specific categories of medical codes to determine their inclusion or exclusion in the primary care definition, particularly concerning contraceptive procedures, domiciliary and rest home care, nursing facility and hospice supervision, interprofessional health assessments, and cognitive impairment care planning. Additionally, the committee received a reminder regarding the application process for the Making Care Primary initiative.

The committee discussed an update from the previous Health Care Cost Transparency Board meeting, which covered facility fee policies and primary care spending recommendations. A presentation on state protections against medical debt was delivered, highlighting the impacts of medical debt on various demographic groups and potential policy interventions such as standardizing financial assistance applications and enhancing collection regulations. Additionally, the committee conducted a policy prioritization discussion, focusing on the need for better data collection, improved enforcement of charity care laws, and addressing high health care costs to mitigate medical debt.